Company News from the 04/07/06 News Brief

Pfizer has entered into an agreement to acquire Rinat Neuroscience, a privately held biotechnology company that is developing therapeutic proteins for the treatment of diseases and disorders of the central nervous system. Financial terms of the deal were not disclosed. Rinat’s lead product has just started Phase II trials as a treatment for osteoarthritis pain.
You must be a registered member of MMM to post a comment.

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.